Copyright
©The Author(s) 2024.
World J Gastrointest Surg. Jun 27, 2024; 16(6): 1803-1824
Published online Jun 27, 2024. doi: 10.4240/wjgs.v16.i6.1803
Published online Jun 27, 2024. doi: 10.4240/wjgs.v16.i6.1803
Figure 1 Technology roadmap.
STAD: Stomach adenocarcinoma; TCGA: The Cancer Genome Atlas; GSEA: Gene Set Enrichment Analysis; GSVA: Gene Set Variation Analysis; LASSO: Least Absolute Shrinkage and Selection Operator; DEGs: Differentially expressed genes; KEGG: Kyoto Encyclopedia of Genes and Genomes; GO: Gene Ontology; PPI: Protein-protein interaction; ROC: Receiver operating characteristic curve.
- Citation: Xie XZ, Zuo L, Huang W, Fan QM, Weng YY, Yao WD, Jiang JL, Jin JQ. FDX1 as a novel biomarker and treatment target for stomach adenocarcinoma. World J Gastrointest Surg 2024; 16(6): 1803-1824
- URL: https://www.wjgnet.com/1948-9366/full/v16/i6/1803.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v16.i6.1803